Approval · Notice of Compliance 8952 · 2007
PHL-LOPERAMIDE: Notice of Compliance 8952
Issued July 30, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8952
- Date
- July 30, 2007
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antidiarrheal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHL-LOPERAMIDE | 02298198 | Cancelled Post Market |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB